These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9863717)

  • 21. Mesenteric vein thrombosis due to factor V Leiden gene mutation.
    Bergenfeldt M; Svensson PJ; Borgström A
    Br J Surg; 1999 Aug; 86(8):1059-62. PubMed ID: 10460643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
    Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
    Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C resistance and factor V Leiden: a review.
    Rosendorff A; Dorfman DM
    Arch Pathol Lab Med; 2007 Jun; 131(6):866-71. PubMed ID: 17550313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors?
    Perrier A
    Chest; 2000 Nov; 118(5):1234-6. PubMed ID: 11083667
    [No Abstract]   [Full Text] [Related]  

  • 26. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
    Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
    Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
    J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APC resistance: biological basis and acquired influences.
    Castoldi E; Rosing J
    J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for thromboembolism.
    Williams E
    Ann Intern Med; 1999 Nov; 131(10):790; author reply 790-1. PubMed ID: 10577307
    [No Abstract]   [Full Text] [Related]  

  • 32. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of factor V Leiden in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Hiyoshi M; Nathalang O; Suwanasophon C; Kokaseam R; Krutvecho T; Tatsumi N
    Asian Pac J Allergy Immunol; 2000 Jun; 18(2):105-8. PubMed ID: 10928623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism.
    Haim N; Lanir N; Hoffman R; Haim A; Tsalik M; Brenner B
    Am J Med; 2001 Feb; 110(2):91-6. PubMed ID: 11165549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for thromboembolism.
    Jay SJ
    Ann Intern Med; 1999 Nov; 131(10):790; author reply 790-1. PubMed ID: 10577306
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood.
    Nowak-Göttl U; Junker R; Hartmeier M; Koch HG; Münchow N; Assmann G; von Eckardstein A
    Circulation; 1999 Aug; 100(7):743-8. PubMed ID: 10449697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.